Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion
- Autores
- Bojko, Barbara; Looby, Nikita; Olkowicz, Mariola; Roszkowska, Anna; Kupcewicz, Bogumiła; Reck des Santos, Pedro; Ramadan, Khaled; Keshavjee, Shaf; Waddell, Thomas K.; Gómez Ríos, German; Tascon, Marcos; Goryński, Krzysztof; Cypel, Marcelo; Pawliszyn, Janusz
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Development of a novel in vivo lung perfusion (IVLP) procedure allows localized delivery of high-dose doxorubicin (DOX) for targeting residual micrometastatic disease in the lungs. However, DOX delivery via IVLP requires careful monitoring of drug level to ensure tissue concentrations of this agent remain in the therapeutic window. A small dimension nitinol wire coated with a sorbent of biocompatible morphology (Bio-SPME) has been clinically evaluated for in vivo lung tissue extraction and determination of DOX and its key metabolites. The in vivo Bio-SPME-IVLP experiments were performed on pig model over various (150 and 225 mg/m2) drug doses, and during human clinical trial. Two patients with metastatic osteosarcoma were treated with a single 5 and 7 μg/mL (respectively) dose of DOX during a 3-h IVLP. In both pig and human cases, DOX tissue levels presented similar trends during IVLP. Human lung tissue concentrations of drug ranged between 15 and 293 μg/g over the course of the IVLP procedure. In addition to DOX levels, Bio-SPME followed by liquid chromatography-mass spectrometry analysis generated 64 metabolic features during endogenous metabolite screening, providing information about lung status during drug administration. Real-time monitoring of DOX levels in the lungs can be performed effectively throughout the IVLP procedure by in vivo Bio-SPME chemical biopsy approach. Bio-SPME also extracted various endogenous molecules, thus providing a real-time snapshot of the physiology of the cells, which might assist in the tailoring of personalized treatment strategy.
Fil: Bojko, Barbara. University of Waterloo; Canadá
Fil: Looby, Nikita. University of Waterloo; Canadá
Fil: Olkowicz, Mariola. University of Waterloo; Canadá
Fil: Roszkowska, Anna. University of Waterloo; Canadá
Fil: Kupcewicz, Bogumiła. Nicolaus Copernicus University in Torun; Polonia
Fil: Reck des Santos, Pedro. University Health Network; Canadá
Fil: Ramadan, Khaled. University Health Network; Canadá
Fil: Keshavjee, Shaf. University Health Network; Canadá
Fil: Waddell, Thomas K.. University Health Network; Canadá
Fil: Gómez Ríos, German. University of Waterloo; Canadá
Fil: Tascon, Marcos. Universidad Nacional de San Martín. Instituto de Investigación e Ingeniería Ambiental. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigación e Ingeniería Ambiental; Argentina
Fil: Goryński, Krzysztof. University of Waterloo; Canadá
Fil: Cypel, Marcelo. University Health Network; Canadá
Fil: Pawliszyn, Janusz. University of Waterloo; Canadá - Materia
-
IN VIVO SOLID PHASE MICROEXTRACTION
METABOLITE PROFILING
SPATIAL RESOLUTION
THERAPEUTIC DRUG MONITORING
TISSUE ANALYSIS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/142888
Ver los metadatos del registro completo
id |
CONICETDig_a694648521ebc6b772a35e5d8fe9d3d8 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/142888 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusionBojko, BarbaraLooby, NikitaOlkowicz, MariolaRoszkowska, AnnaKupcewicz, BogumiłaReck des Santos, PedroRamadan, KhaledKeshavjee, ShafWaddell, Thomas K.Gómez Ríos, GermanTascon, MarcosGoryński, KrzysztofCypel, MarceloPawliszyn, JanuszIN VIVO SOLID PHASE MICROEXTRACTIONMETABOLITE PROFILINGSPATIAL RESOLUTIONTHERAPEUTIC DRUG MONITORINGTISSUE ANALYSIShttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Development of a novel in vivo lung perfusion (IVLP) procedure allows localized delivery of high-dose doxorubicin (DOX) for targeting residual micrometastatic disease in the lungs. However, DOX delivery via IVLP requires careful monitoring of drug level to ensure tissue concentrations of this agent remain in the therapeutic window. A small dimension nitinol wire coated with a sorbent of biocompatible morphology (Bio-SPME) has been clinically evaluated for in vivo lung tissue extraction and determination of DOX and its key metabolites. The in vivo Bio-SPME-IVLP experiments were performed on pig model over various (150 and 225 mg/m2) drug doses, and during human clinical trial. Two patients with metastatic osteosarcoma were treated with a single 5 and 7 μg/mL (respectively) dose of DOX during a 3-h IVLP. In both pig and human cases, DOX tissue levels presented similar trends during IVLP. Human lung tissue concentrations of drug ranged between 15 and 293 μg/g over the course of the IVLP procedure. In addition to DOX levels, Bio-SPME followed by liquid chromatography-mass spectrometry analysis generated 64 metabolic features during endogenous metabolite screening, providing information about lung status during drug administration. Real-time monitoring of DOX levels in the lungs can be performed effectively throughout the IVLP procedure by in vivo Bio-SPME chemical biopsy approach. Bio-SPME also extracted various endogenous molecules, thus providing a real-time snapshot of the physiology of the cells, which might assist in the tailoring of personalized treatment strategy.Fil: Bojko, Barbara. University of Waterloo; CanadáFil: Looby, Nikita. University of Waterloo; CanadáFil: Olkowicz, Mariola. University of Waterloo; CanadáFil: Roszkowska, Anna. University of Waterloo; CanadáFil: Kupcewicz, Bogumiła. Nicolaus Copernicus University in Torun; PoloniaFil: Reck des Santos, Pedro. University Health Network; CanadáFil: Ramadan, Khaled. University Health Network; CanadáFil: Keshavjee, Shaf. University Health Network; CanadáFil: Waddell, Thomas K.. University Health Network; CanadáFil: Gómez Ríos, German. University of Waterloo; CanadáFil: Tascon, Marcos. Universidad Nacional de San Martín. Instituto de Investigación e Ingeniería Ambiental. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigación e Ingeniería Ambiental; ArgentinaFil: Goryński, Krzysztof. University of Waterloo; CanadáFil: Cypel, Marcelo. University Health Network; CanadáFil: Pawliszyn, Janusz. University of Waterloo; CanadáElsevier2021-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/142888Bojko, Barbara; Looby, Nikita; Olkowicz, Mariola; Roszkowska, Anna; Kupcewicz, Bogumiła; et al.; Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion; Elsevier; Journal of Pharmaceutical Analysis; 11; 1; 2-2021; 37-472095-1779CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S2095177920310546info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jpha.2020.08.011info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:25:33Zoai:ri.conicet.gov.ar:11336/142888instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:25:34.098CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion |
title |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion |
spellingShingle |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion Bojko, Barbara IN VIVO SOLID PHASE MICROEXTRACTION METABOLITE PROFILING SPATIAL RESOLUTION THERAPEUTIC DRUG MONITORING TISSUE ANALYSIS |
title_short |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion |
title_full |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion |
title_fullStr |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion |
title_full_unstemmed |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion |
title_sort |
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion |
dc.creator.none.fl_str_mv |
Bojko, Barbara Looby, Nikita Olkowicz, Mariola Roszkowska, Anna Kupcewicz, Bogumiła Reck des Santos, Pedro Ramadan, Khaled Keshavjee, Shaf Waddell, Thomas K. Gómez Ríos, German Tascon, Marcos Goryński, Krzysztof Cypel, Marcelo Pawliszyn, Janusz |
author |
Bojko, Barbara |
author_facet |
Bojko, Barbara Looby, Nikita Olkowicz, Mariola Roszkowska, Anna Kupcewicz, Bogumiła Reck des Santos, Pedro Ramadan, Khaled Keshavjee, Shaf Waddell, Thomas K. Gómez Ríos, German Tascon, Marcos Goryński, Krzysztof Cypel, Marcelo Pawliszyn, Janusz |
author_role |
author |
author2 |
Looby, Nikita Olkowicz, Mariola Roszkowska, Anna Kupcewicz, Bogumiła Reck des Santos, Pedro Ramadan, Khaled Keshavjee, Shaf Waddell, Thomas K. Gómez Ríos, German Tascon, Marcos Goryński, Krzysztof Cypel, Marcelo Pawliszyn, Janusz |
author2_role |
author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
IN VIVO SOLID PHASE MICROEXTRACTION METABOLITE PROFILING SPATIAL RESOLUTION THERAPEUTIC DRUG MONITORING TISSUE ANALYSIS |
topic |
IN VIVO SOLID PHASE MICROEXTRACTION METABOLITE PROFILING SPATIAL RESOLUTION THERAPEUTIC DRUG MONITORING TISSUE ANALYSIS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Development of a novel in vivo lung perfusion (IVLP) procedure allows localized delivery of high-dose doxorubicin (DOX) for targeting residual micrometastatic disease in the lungs. However, DOX delivery via IVLP requires careful monitoring of drug level to ensure tissue concentrations of this agent remain in the therapeutic window. A small dimension nitinol wire coated with a sorbent of biocompatible morphology (Bio-SPME) has been clinically evaluated for in vivo lung tissue extraction and determination of DOX and its key metabolites. The in vivo Bio-SPME-IVLP experiments were performed on pig model over various (150 and 225 mg/m2) drug doses, and during human clinical trial. Two patients with metastatic osteosarcoma were treated with a single 5 and 7 μg/mL (respectively) dose of DOX during a 3-h IVLP. In both pig and human cases, DOX tissue levels presented similar trends during IVLP. Human lung tissue concentrations of drug ranged between 15 and 293 μg/g over the course of the IVLP procedure. In addition to DOX levels, Bio-SPME followed by liquid chromatography-mass spectrometry analysis generated 64 metabolic features during endogenous metabolite screening, providing information about lung status during drug administration. Real-time monitoring of DOX levels in the lungs can be performed effectively throughout the IVLP procedure by in vivo Bio-SPME chemical biopsy approach. Bio-SPME also extracted various endogenous molecules, thus providing a real-time snapshot of the physiology of the cells, which might assist in the tailoring of personalized treatment strategy. Fil: Bojko, Barbara. University of Waterloo; Canadá Fil: Looby, Nikita. University of Waterloo; Canadá Fil: Olkowicz, Mariola. University of Waterloo; Canadá Fil: Roszkowska, Anna. University of Waterloo; Canadá Fil: Kupcewicz, Bogumiła. Nicolaus Copernicus University in Torun; Polonia Fil: Reck des Santos, Pedro. University Health Network; Canadá Fil: Ramadan, Khaled. University Health Network; Canadá Fil: Keshavjee, Shaf. University Health Network; Canadá Fil: Waddell, Thomas K.. University Health Network; Canadá Fil: Gómez Ríos, German. University of Waterloo; Canadá Fil: Tascon, Marcos. Universidad Nacional de San Martín. Instituto de Investigación e Ingeniería Ambiental. - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigación e Ingeniería Ambiental; Argentina Fil: Goryński, Krzysztof. University of Waterloo; Canadá Fil: Cypel, Marcelo. University Health Network; Canadá Fil: Pawliszyn, Janusz. University of Waterloo; Canadá |
description |
Development of a novel in vivo lung perfusion (IVLP) procedure allows localized delivery of high-dose doxorubicin (DOX) for targeting residual micrometastatic disease in the lungs. However, DOX delivery via IVLP requires careful monitoring of drug level to ensure tissue concentrations of this agent remain in the therapeutic window. A small dimension nitinol wire coated with a sorbent of biocompatible morphology (Bio-SPME) has been clinically evaluated for in vivo lung tissue extraction and determination of DOX and its key metabolites. The in vivo Bio-SPME-IVLP experiments were performed on pig model over various (150 and 225 mg/m2) drug doses, and during human clinical trial. Two patients with metastatic osteosarcoma were treated with a single 5 and 7 μg/mL (respectively) dose of DOX during a 3-h IVLP. In both pig and human cases, DOX tissue levels presented similar trends during IVLP. Human lung tissue concentrations of drug ranged between 15 and 293 μg/g over the course of the IVLP procedure. In addition to DOX levels, Bio-SPME followed by liquid chromatography-mass spectrometry analysis generated 64 metabolic features during endogenous metabolite screening, providing information about lung status during drug administration. Real-time monitoring of DOX levels in the lungs can be performed effectively throughout the IVLP procedure by in vivo Bio-SPME chemical biopsy approach. Bio-SPME also extracted various endogenous molecules, thus providing a real-time snapshot of the physiology of the cells, which might assist in the tailoring of personalized treatment strategy. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-02 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/142888 Bojko, Barbara; Looby, Nikita; Olkowicz, Mariola; Roszkowska, Anna; Kupcewicz, Bogumiła; et al.; Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion; Elsevier; Journal of Pharmaceutical Analysis; 11; 1; 2-2021; 37-47 2095-1779 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/142888 |
identifier_str_mv |
Bojko, Barbara; Looby, Nikita; Olkowicz, Mariola; Roszkowska, Anna; Kupcewicz, Bogumiła; et al.; Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion; Elsevier; Journal of Pharmaceutical Analysis; 11; 1; 2-2021; 37-47 2095-1779 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://linkinghub.elsevier.com/retrieve/pii/S2095177920310546 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jpha.2020.08.011 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614254643118080 |
score |
13.070432 |